# Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

> **NCT00462488** · PHASE2 · COMPLETED · sponsor: **Sesen Bio, Inc.** · enrollment: 46 (actual)

## Conditions studied

- Urinary Bladder Cancer
- Bladder Cancer
- Bladder Neoplasms
- Bladder Tumors

## Interventions

- **DRUG:** Vicinium

## Key facts

- **NCT ID:** NCT00462488
- **Lead sponsor:** Sesen Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462488, "Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00462488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*